However, despite great benefits, clinical studies have shown that not all patients respond to anti‐VEGF treatments, which could be accounted by the fact that choroidal neovascularization (CNV) associated with AMD is a multifactorial condition whose pathogenesis involves inflammation, angiogenesis, and fibrosis (Kieran et al, 2012; Yang et al, 2016). This evidence concerns the gene VEGFA and age-related macular degeneration.